Tellgen Corporation's Subsidiary Secures Medical Device Registration for Fully Automated Chemiluminescence Immunoassay Analyzer

Stock News

06/29

Tellgen Corporation (SZSE: 300642) has announced that its wholly-owned subsidiary, Jiangxi Tellgen Life Technology Co., Ltd., has recently obtained a medical device registration certificate from the Jiangxi Provincial Medical Products Administration.

The certificate pertains to the "Fully Automated Chemiluminescence Immunoassay Analyzer." The acquisition of this registration enriches the instrument portfolio supporting the company's and the subsidiary's chemiluminescence product line.

This development is expected to facilitate the expansion of the company's products across various application scenarios. It will further strengthen the overall competitiveness of Tellgen Corporation and its subsidiary within the in-vitro diagnostics field and is anticipated to enhance market expansion capabilities.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1147852283"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1147852283\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1147852283?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-29 18:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1147852283","market":"sh","top_or_hot":-1,"title":"Tellgen Corporation's Subsidiary Secures Medical Device Registration for Fully Automated Chemiluminescence Immunoassay Analyzer","media":"Stock News","content":"<p>Tellgen Corporation (SZSE: 300642) has announced that its wholly-owned subsidiary, Jiangxi Tellgen Life Technology Co., Ltd., has recently obtained a medical device registration certificate from the Jiangxi Provincial Medical Products Administration.<br><br>The certificate pertains to the \"Fully Automated Chemiluminescence Immunoassay Analyzer.\" The acquisition of this registration enriches the instrument portfolio supporting the company's and the subsidiary's chemiluminescence product line.<br><br>This development is expected to facilitate the expansion of the company's products across various application scenarios. It will further strengthen the overall competitiveness of <b>Tellgen Corporation</b> and its subsidiary within the in-vitro diagnostics field and is anticipated to enhance market expansion capabilities.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tellgen Corporation's Subsidiary Secures Medical Device Registration for Fully Automated Chemiluminescence Immunoassay Analyzer</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTellgen Corporation's Subsidiary Secures Medical Device Registration for Fully Automated Chemiluminescence Immunoassay Analyzer\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-06-29 18:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Tellgen Corporation (SZSE: 300642) has announced that its wholly-owned subsidiary, Jiangxi Tellgen Life Technology Co., Ltd., has recently obtained a medical device registration certificate from the Jiangxi Provincial Medical Products Administration.<br><br>The certificate pertains to the \"Fully Automated Chemiluminescence Immunoassay Analyzer.\" The acquisition of this registration enriches the instrument portfolio supporting the company's and the subsidiary's chemiluminescence product line.<br><br>This development is expected to facilitate the expansion of the company's products across various application scenarios. It will further strengthen the overall competitiveness of <b>Tellgen Corporation</b> and its subsidiary within the in-vitro diagnostics field and is anticipated to enhance market expansion capabilities.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1574","symbol_name":"生物医药B类股","start_time":0,"source_url":"","article_id":"1147852283","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1147852283","pubTimestamp":1782727224,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Tellgen Corporation (SZSE: 300642) has announced that its wholly-owned subsidiary, Jiangxi Tellgen Life Technology Co., Ltd., has recently obtained a medical device registration certificate from the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159883":"医疗器械","300642":"透景生命","BK1574":"生物医药B类股","BK0042":"基因检测","BK0239":"医药制造","BK0046":"生物疫苗","09996":"沛嘉医疗-B","BK1583":"高瓴概念","BK1100":"医疗保健设备"},"translate_title":"Tellgen Corporation子公司获得全自动化学发光免疫分析仪医疗器械注册","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159883":1,"300642":1,"09996":1},"content_text":"Tellgen Corporation (SZSE: 300642) has announced that its wholly-owned subsidiary, Jiangxi Tellgen Life Technology Co., Ltd., has recently obtained a medical device registration certificate from the Jiangxi Provincial Medical Products Administration.The certificate pertains to the \"Fully Automated Chemiluminescence Immunoassay Analyzer.\" The acquisition of this registration enriches the instrument portfolio supporting the company's and the subsidiary's chemiluminescence product line.This development is expected to facilitate the expansion of the company's products across various application scenarios. It will further strengthen the overall competitiveness of Tellgen Corporation and its subsidiary within the in-vitro diagnostics field and is anticipated to enhance market expansion capabilities.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}